[1] YU Y,HANN S S.Novel tumor suppressor lncRNA growth arrest-specific 5(GAS5) in human cancer[J].Onco Targets Ther,2019,12:8421.
[2] LAMBROU G I,HATZIAGAPIOU K,ZARAVINOS A.The non-coding RNA GAS5 and its role in tumor therapy-induced resistance[J].Int J Mol Sci,2020,21(20):7633.
[3] PICKARD M R,WILLIAMS G T.Molecular and cellular mechanisms of action of tumour suppressor GAS5 LncRNA[J].Genes,2015,6(3):484-499.
[4] SALMENA L,POLISENO L,TAY Y,et al.A ceRNA hypothesis:the Rosetta Stone of a hidden RNA language?[J].Cell,2011,146(3):353-358.
[5] KOPP F,MENDELL J T.Functional classification and experimental dissection of long noncoding RNAs[J].Cell,2018,172(3):393-407.
[6] LI J,HUANG H,LI Y,et al.Decreased expression of long non-coding RNA GAS5 promotes cell proliferation,migration and invasion,and indicates a poor prognosis in ovarian cancer[J].Oncology Reports,2016,36(6):3241-3250.
[7] GAO J,LIU M,ZOU Y,et al.Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway[J].Oncology Reports,2015,34(6):3212-3221.
[8] CILLO C,CANTILE M,FAIELLA A,et al.Homeobox genes in normal and malignant cells[J].J Cell Physiol,2001,188(2):161-169.
[9] MA H M,CUI N,ZHENG P S.HOXA5 inhibits the proliferation and neoplasia of cervical cancer cells via downregulating the activity of the Wnt/β-catenin pathway and transactivating TP53[J].Cell Death Dis,2020,11(6):1-15.
[10] LI B,HUANG Q,WEI G H.The role of HOX transcription factors in cancer predisposition and progression[J].Cancers,2019,11(4):528.
[11] WU Y,ZHOU T,TANG Q,et al.HOXA5 inhibits tumor growth of gastric cancer under the regulation of microRNA-196a[J].Gene,2019,681:62-68.
[12] GJYSHI A,DASH S,CEN L,et al.Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine[J].Scientific Reports,2018,8(1):1-11.
[13] RHOADS K,ARDERIU G,CHARBONEAU A,et al.A role for Hox A5 in regulating angiogenesis and vascular patterning[J].Lymphatic Res Biol,2005,3(4):240-252.
[14] KUNG J T Y,COLOGNORI D,LEE J T.Long noncoding RNAs:past,present,and future[J].Genetics,2013,193(3):651-669.
[15] GUAN D,ZHANG W,LIU G H,et al.Switching cell fate,ncRNAs coming to play[J].Cell Death Dis,2013,4(1):e464.
[16] LI S,ZHOU J,WANG Z,et al.Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p[J].Biomed Pharmacother,2018,104:451-457.
[17] LIU Y,ZHAO J,ZHANG W,et al.lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer[J].Scientific Reports,2015,5(1):1-12.
[18] LIU Y,YIN L,CHEN C,et al.Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein[J].Dig Liver Dis,2020,52(3):331-338.
[19] RAMAN V,MARTENSEN S A,REISMAN D,et al.Compromised HOXA5 function can limit p53 expression in human breast tumours[J].Nature,2000,405(6789):974-978.
[20] STASINOPOULOS I A,MIRONCHIK Y,RAMAN A,et al.HOXA5-twist interaction alters p53 homeostasis in breast cancer cells[J].J Biol Chem,2005,280(3):2294-2299.
[21] STRATHDEE G,SIM A,SOUTAR R,et al.HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia[J].Carcinogenesis,2007,28(2):299-309.
[22] ORDÓÑEZ-MORÁN P,DAFFLON C,IMAJO M,et al.HOXA5 counteracts stem cell traits by inhibiting Wnt signaling in colorectal cancer[J].Cancer cell,2015,28(6):815-829.
[23] HISS D.Optimizing molecular-targeted therapies in ovarian cancer:the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways[J].J Oncol,2012,2012:737981.
[24] DHILLON K K,SWISHER E M,TANIGUCHI T.Secondary mutations of BRCA1/2 and drug resistance[J].Cancer Science,2011,102(4):663-669.
[25] SAKAI W,SWISHER E M,KARLAN B Y,et al.Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers[J].Nature,2008,451(7182):1116-1120.
[26] PENG X,ZHA L,CHEN A,et al.HOXA5 is a tumor suppressor gene that is decreased in gastric cancer[J].Oncology Reports,2018,40(3):317-1329.
[27] ZHAO H,YU H,ZHENG J,et al.Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5[J].Gynecologic Oncology,2018,151(2):345-355.
[28] TRIPATHI M K,DOXTATER K,KERAMATNIA F, et al.Role of lncRNAs in ovarian cancer:defining new biomarkers for therapeutic purposes[J].Drug Discov Today,2018,23:1635-1643.
[29] KIM K,PARK E Y,YOON M S,et al.The role of TWIST in ovarian epithelial cancers[J].Korean J Pathol,2014,48:283-291.
[30] PENG J,QI S,WANG P,et al.Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer[J].Future Oncology,2016,12(5):715-726.
[31] STASINOPOULOS I A,MIRONCHIK Y,RAMAN A,et al.HOXA5-twist interaction alters p53 homeostasis in breast cancer cells[J].J Biol Chem,2005,280(3):2294-2299.
[32] YANG W L,LU Z,GUO J,et al.Human epididymis protein 4 antigen autoantibody complexes complement cancer antigen 125 for detecting early stage ovarian cancer[J].Cancer,2020,126(4):725-736.
[33] DING F,CHEN P,BIE P,et al.HOXA5 Is recognized as a prognostic-related biomarker and promotes glioma progression through affecting cell cycle[J].Front Oncol,2021,11:633430.
[34] ZHAO X,LIU Y,ZHENG J,et al.GAS5 suppresses malignancy of human glioma stem cells via a miR-196a-5p/FOXO1 feedback loop[J].Biochim Biophys Acta,2017,1864(10):1605-1617.
[35] LIU X,LU K,WANG K,et al.MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5[J].BMC Cancer,2012,12:348. |
